Publication: HCC risk scores: Application of the CU-HCC, GAG-HCC and page-B scores to chronic hepatitis B (CHB) patients treated with tenofovir disoproxil fumarate (TDF)
dc.contributor.author | Kim, W. R. | |
dc.contributor.author | Loomba, R. | |
dc.contributor.author | Berg, T. | |
dc.contributor.author | Schall, R. Aguilar | |
dc.contributor.author | Yee, L. | |
dc.contributor.author | Dinh, P. | |
dc.contributor.author | Flaherty, J. F. | |
dc.contributor.author | Martins, E. B. | |
dc.contributor.author | Jacobson, I. | |
dc.contributor.author | Fung, S. | |
dc.contributor.author | Gürel, S. | |
dc.contributor.author | Buti, M. | |
dc.contributor.author | Marcellin, P. | |
dc.contributor.buuauthor | GÜREL, SELİM | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı. | |
dc.contributor.researcherid | HLH-8209-2023 | |
dc.date.accessioned | 2024-08-06T08:04:51Z | |
dc.date.available | 2024-08-06T08:04:51Z | |
dc.date.issued | 2015-04-01 | |
dc.description | Bu çalışma, 22-26, Nisan 2015 tarihlerinde Vienna[Avusturya]’da düzenlenen 50. International Liver Congress of the European-Association-for-the-Study-of-the-Liver Kongresi‘nde bildiri olarak sunulmuştur. | |
dc.description.sponsorship | European Assoc Study Liver | |
dc.identifier.doi | 10.1016/S0168-8278(15)30849-7 | |
dc.identifier.endpage | S561 | |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issue | Supplement 2 | |
dc.identifier.startpage | S561 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0168827815308497 | |
dc.identifier.uri | https://doi.org/10.1016/S0168-8278(15)30849-7 | |
dc.identifier.uri | https://hdl.handle.net/11452/43747 | |
dc.identifier.volume | 62 | |
dc.identifier.wos | 000362830600361 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | Elsevier Science | |
dc.relation.journal | Journal of Hepatology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Gastroenterology & hepatology | |
dc.title | HCC risk scores: Application of the CU-HCC, GAG-HCC and page-B scores to chronic hepatitis B (CHB) patients treated with tenofovir disoproxil fumarate (TDF) | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | d7a9ea11-69fc-4122-a365-8fb2123512e6 | |
relation.isAuthorOfPublication.latestForDiscovery | d7a9ea11-69fc-4122-a365-8fb2123512e6 |